QDEL QuidelOrtho: תחזית צמיחת רווח נקי למניה לשנה הבאה

QuidelOrtho (QDEL) faces risks associated with a slowdown in new deals and FDA oversight. However, the company is mitigating its dependence on external suppliers through strategic stockpiling and is monetizing customer loyalty via price indexing for consumables. Analyzing the market expectations for EPS growth on GURU.Markets, we note a support level where 97.40 reflects the most recent value of the metric.

This indicator assesses average expert expectations for net earnings per share growth rates, allowing for a comparison between the company's market value and its future operational efficiency. The trend in projected earnings per share for the coming year reflects QuidelOrtho (QDEL) emerging from the pandemic slump and the successful implementation of new laboratory platforms to restore business margins.